Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
443 hedge funds and large institutions have $7.39B invested in Abiomed Inc in 2019 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 180 increasing their positions, 148 reducing their positions, and 89 closing their positions.
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
22% more repeat investments, than reductions
Existing positions increased: 180 | Existing positions reduced: 148
8% less funds holding
Funds holding: 483 → 443 (-40)
32% less capital invested
Capital invested by funds: $10.9B → $7.39B (-$3.53B)
42% less call options, than puts
Call options by funds: $107M | Put options by funds: $185M
44% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 89
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$112M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$103M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$102M |
| 4 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$57.9M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$46.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$64M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$56.9M |
| 3 |
Two Sigma Advisers
New York
|
-$49.1M |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$46.6M |
| 5 |
Sands Capital Management
Arlington,
Virginia
|
-$42.3M |
ABMD Hedge Fund Activity: Q3 2019 in Review
443 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q3 2019, worth a combined $7.39B — down 32% from $10.9B a quarter earlier.
Sellers outnumbered buyers: 89 funds closed out of ABMD and 50 opened new positions — a net loss of 39 holders — while 148 trimmed existing stakes and 180 added.
The largest buyer was AllianceBernstein, adding an estimated $112M. The largest seller was Renaissance Technologies, cutting an estimated $64M.
- 443 institutional investors held Abiomed Inc (ABMD) as of Q3 2019, down from 483 in Q2 2019.
- Funds reported $7.39B of Abiomed Inc stock for Q3 2019, down 32% quarter-over-quarter.
- 50 funds opened new Abiomed Inc positions in Q3 2019 and 89 closed out, a net change of -39 holders.
- The largest Abiomed Inc buyer in Q3 2019 was AllianceBernstein, an estimated $112M added.
- The largest Abiomed Inc seller in Q3 2019 was Renaissance Technologies, an estimated $64M sold.
Based on aggregated 13F filings for Q3 2019.